Aquestive Therapeutics In... (AQST)
NASDAQ: AQST
· Real-Time Price · USD
7.34
0.46 (6.69%)
At close: Oct 15, 2025, 3:59 PM
7.42
1.09%
After-hours: Oct 15, 2025, 04:39 PM EDT
6.69% (1D)
| Bid | 7.34 |
| Market Cap | 732.02M |
| Revenue (ttm) | 44.13M |
| Net Income (ttm) | -65.04M |
| EPS (ttm) | -0.69 |
| PE Ratio (ttm) | -10.64 |
| Forward PE | -11.48 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 7.63 |
| Volume | 4,774,195 |
| Avg. Volume (20D) | 2,938,812.2 |
| Open | 7.00 |
| Previous Close | 6.88 |
| Day's Range | 6.89 - 7.51 |
| 52-Week Range | 2.12 - 7.50 |
| Beta | 1.76 |
| Ex-Dividend Date | n/a |
About AQST
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AQST
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AQST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAquestive Therapeutics Inc. is scheduled to release its earnings on
Nov 3, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
+7.9%
Aquestive Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
1 month ago
+28.1%
Aquestive Therapeutics shares are trading higher after the FDA said it will not require an advisory committee meeting to discuss the New Drug Application for Anaphylm.
